AIHealthcare

EZRA is a New York-based healthcare AI company that provides full-body MRI screening services intended to support earlier cancer detection. Its model combines medical imaging, AI-assisted image analysis, and clinical review, delivered through imaging-center partners. The company describes its offering as a consumer-accessible full-body cancer-screening service; its AI work includes MRI image-analysis software, with the company reporting FDA clearance for aspects of its technology. In February 2024, EZRA said it would use new capital to expand to 20 cities and 50 North American locations during that year and to advance use of its AI technology by imaging centers and clinicians. Its market position is therefore in the growing full-body MRI/early-detection screening segment, rather than diagnostic care or treatment delivery.